The prevalence of diabetes among adults aged 40 years and over in Fiji

New Zealand Medical Journal

Volumn 123, Issue 1327, 2010, Pages 68-75

  Brian, Garry ^a   Ramke, Jacqueline ^a   Maher, Louise ^a   Page, Andrew ^a   Szetu, John ^a  

^a Fred Hollows Foundation New Zealand   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ETHNICITY; FEMALE; FIJI; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SEX DIFFERENCE; VISUAL IMPAIRMENT;

ADULT; AGE DISTRIBUTION; AGE FACTORS; AGED; CLUSTER ANALYSIS; DIABETES MELLITUS; ETHNIC GROUPS; FEMALE; FIJI; HEALTH SURVEYS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; SEX DISTRIBUTION;

EID: 78650743372     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Omran A. The epidemiological transition: a theory of the epidemiology of population change. Milbank Memorial Fund Quarterly. 1971;49(4):509-38.
2. Caldwell JC. Population health in transition. Bull World Health Organ. 2001;79(2):159-60.
3. Wahdan M. The epidemiological transition. Eastern Mediterranean Health Journal. 1996;2(1):8-20.
4. United Nations Development Programme. Human Development Report 2009. Overcoming barriers: human mobility and development. United Nations Development Programme. New York, 2009.
5. Ministry of Health. Ministry of Health Annual Report 2005. Government of the Republic of the Fiji Islands. Suva, 2005. http://www.health.gov.fj/ Annual%20Report/2005.html
6. Cornelius M, Decourten M, Pryor J, et al. Fiji Non-communicable Diseases (NCD) STEPS Survey, 2002. http://www.who.int/chp/steps/FijiSTEPSReport.pdf
7. Cassidy JT. Diabetes in Fiji. NZ Med J. 1967;66(415):167-72.
8. Zimmet P, Taylor R, Ram P, et al. Prevalence of diabetes and impaired glucose tolerance in the biracial (Melanesian and Indian) population of Fiji: a rural-urban comparison. Am J Epidemiol. 1983;118(5):673-88.
9. Ministry of Health. National Non-communicable Diseases Strategic Plan 2004-2008. Government of the Republic of the Fiji Islands. Suva, 2004.
10. Gillett MJ. International Expert Committee Report on the Role of the A1c Assay in the Diagnosis of Diabetes. Diabetes Care. 2009;32(7):1327-34
11. Clin Biochem Rev. 2009;30(4):197-200.
12. Kilpatrick ES, Bloomgarden ZT, Zimmet PZ. Is haemoglobin A1c a step forward for diagnosing diabetes? BMJ. 2009;339:b4432.
13. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(Suppl 1):S62-S69.
14. Kilpatrick ES. Haemoglobin A1c in the diagnosis and monitoring of diabetes mellitus. J Clin Pathol. 2008;61(9):977-82.
15. Rohlfing CL, Little RR, Wiedmeyer HM, et al. Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population. Diabetes Care. 2000;23(2):187-91.
16. Ginde AA, Cagliero E, Nathan DM, Camargo CA, Jr. Value of risk stratification to increase the predictive validity of HbA1c in screening for undiagnosed diabetes in the US population. J Gen Intern Med. 2008;23(9):1346-53.
17. Shemesh T, Rowley KG, Shephard M, et al. Agreement between laboratory results and on-site pathology testing using Bayer DCA2000+ and Cholestech LDX point-of-care methods in remote Australian Aboriginal communities. Clin Chim Acta. 2006;367(1-2):69-76.
18. Buchanan JG, Jha BK, Matthews JR, Nixon AD. The prevalence and nature of anemia among apparently normal subjects in Fiji. Pathology. 1979;11(3):369-76.
19. Hoskins PL, Handelsman DJ, Hannelly T, et al. Diabetes in the Melanesian and Indian peoples of Fiji: a study of risk factors. Diabetes Res Clin Pract. 1987;3(5):269-76.
20. International Diabetes Federation. Table 1.37 in International Diabetes Federation Diabetes Atlas. 4th ed. International Diabetes Federation. Brussels, 2009. http://www.diabetesatlas.org/content/prevalence-estimates-diabetes- mellitus-dm-2010